Submission Details
| 510(k) Number | K233130 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 27, 2023 |
| Decision Date | December 20, 2023 |
| Days to Decision | 84 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K233130 is an FDA 510(k) clearance for the Blood Pressure Monitor, a System, Measurement, Blood-pressure, Non-invasive (Class II — Special Controls, product code DXN), submitted by Guangdong Transtek Medical Electronics Co., Ltd. (Zhongshan, CN). The FDA issued a Cleared decision on December 20, 2023, 84 days after receiving the submission on September 27, 2023. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.1130.
| 510(k) Number | K233130 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 27, 2023 |
| Decision Date | December 20, 2023 |
| Days to Decision | 84 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | DXN — System, Measurement, Blood-pressure, Non-invasive |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.1130 |